• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 276
  • 264
  • 72
  • 27
  • 17
  • 9
  • 8
  • 7
  • 4
  • 4
  • 4
  • 2
  • 2
  • 1
  • 1
  • Tagged with
  • 779
  • 779
  • 270
  • 265
  • 229
  • 109
  • 101
  • 100
  • 98
  • 97
  • 90
  • 84
  • 76
  • 76
  • 75
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
711

The Effects of Testicular Nerve Transection and Epididymal White Adipose Tissue Lipectomy on Spermatogenesis in Syrian Hamster

Spence, Jeremiah E. 30 July 2008 (has links)
Previous investigators demonstrated that epididymal white adipose tissue (EWAT) lipectomy suppressed spermatogenesis and caused atrophy of the seminiferous tubules. EWAT lipectomy, however, may disrupt testicular innervation, which reportedly compromises testicular function. To resolve this confound and better clarify the role of EWAT in spermatogenesis, three experimental groups of hamsters were created in which: i.) the superior and inferior spermatic nerves were transected (SSNx) at the testicular level, ii.) EWAT was extirpated (EWATx), and iii.) testicular nerves and EWAT were left intact (SHAM controls). It was hypothesized that transection of the superior and inferior spermatic nerves would disrupt normal spermatogenesis. The findings indicate a significant reduction in spermatogenic activity and marked seminal tubule atrophy within the EWATx testis, as compared to the SSNx and controls testes, which did not differ significantly from each other. From these data, it is concluded that EWAT, and not testicular innervation, is central to normal spermatogenesis.
712

Contribution différentielle du tissu adipeux mâle et femelle dans l’établissement du diabète de type 2 et des altérations cardiovasculaires : rôle de l’apport lipidique

El Akoum, Souhad 09 1900 (has links)
Au cours des dernières années, il est devenu évident que les sociétés des pays industrialisés sont à haut risque de maladies métaboliques. Une alimentation riche en énergie (lipide/glucide), combinée à une sédentarité accrue, est un facteur environnemental contribuant à l'augmentation de la prévalence de maladies reliées spécifiquement à des troubles endocriniens comme l'obésité et le diabète. Le traitement de ces désordres métaboliques doit donc passer par la connaissance et la compréhension des mécanismes moléculaires qui contrôlent ces désordres et le développement de traitements ciblés vers les facteurs responsables. Le tissu adipeux est une glande endocrine qui sécrète des substances, regroupées sous le terme d'adipokines, qui contrôlent l'homéostasie énergétique. L'augmentation de la masse adipeuse est responsable du développement de dérégulation hormonale qui mène à des dysfonctions physiologiques et métaboliques. Pour contrecarrer le développement démesuré du tissu adipeux, la signalisation insulinique ainsi que l’apport énergétique, responsables de la différenciation adipocytaire, doivent être inhibés. In vivo, la leptine, adipokine dont la concentration est corrélée à la masse adipeuse, présente des actions pro ou anti-insuliniques dans l’organisme pour réguler ce phénomène. Elle favorise l’effet inhibiteur de l’insuline sur la synthèse hépatique de glucose alors qu’elle s’oppose à son action sur l’expression des enzymes glucokinase et phosphoénol-pyruvate carboxykinase. La leptine influence aussi le taux circulant de triglycérides en diminuant sa concentration plasmatique. D'autre part, l'adiponectine, adipokine insulino- sensibilisante, voit sa sécrétion diminuée avec la prise de poids. La sensibilité à l'insuline est ainsi diminuée au fur et à mesure que le débalancement de ces deux adipokines s'accentue. La résistance à l'insuline s'installe alors pour s'opposer au stockage énergétique et à la prise illimitée de poids et la glycémie augmente. L'augmentation du glucose sanguin stimule la sécrétion d'insuline au niveau des cellules pancréatiques. C'est le diabète caractérisé par une hyperglycémie et une résistance à l'insuline. Le diabète, une des premières causes de mortalité dans le monde, est plus répandu sous sa forme non insulinodépendante (diabète de type 2, DT2) liée à l'obésité. Récemment, différents facteurs de transcription ont été identifiés comme régulateurs de l'expression d'une panoplie de gènes impliqués dans le métabolisme glucidique et lipidique. Parmi eux, les récepteurs des inducteurs de la prolifération des peroxysomes (PPAR, Peroxisome Proliferator-Activated Receptor), appartenant à la famille des récepteurs nucléaires. Les PPAR ont été démontrés comme ayant un rôle central dans le contrôle de la transcription des gènes codants pour des protéines impliquées dans le métabolisme : les adipokines. PPARg, en plus de son implication dans le contrôle de l'homéostasie glucidique et lipidique, est reconnu comme étant un facteur de transcription pivot régulant l'adipogenèse du fait de son expression majeure dans le tissu adipeux. D'autre part, il est bien établi maintenant que l'obésité et le diabète sont des facteurs contribuant au développement du processus inflammatoire vasculaire caractéristique de l’athérosclérose. En effet, les cellules endothéliales et musculaires lisses, principales composantes de la média de l’artère, sont très sensibles aux altérations métaboliques. Une diminution de la sensibilité à l’insuline entraine une réduction de la disponibilité du glucose et l’utilisation des acides gras comme alternatif par ces cellules. Ceci induit l’accumulation des acides gras oxydés dans l’intima et leur filtration dans la média pour former un core lipidique. Bien que l’induction de la dysfonction endothéliale soit impliquée très précocement, certaines études pointent l’accumulation lipidique dans les cellules musculaires lisses vasculaires (CML) et leur dysfonction comme déclencheurs de l’athérosclérose. Ce travail visait donc, dans un premier temps, à développer un modèle d'altérations métaboliques liées à la modulation de l'activité du tissu adipeux via une alimentation riche en lipides. Dans un second temps, cette étude tentait d'évaluer l’impact des adipocytes de souris sur les CML vasculaires et sur la modulation de leurs fonctions dans ce modèle d'altérations métaboliques et DT2 liés à l'alimentation et à l'obésité. Ainsi, par le biais de deux diètes pauvres en cholestérol à profil lipidique différent, nous avons développé un modèle murin présentant divers stades d'altérations du métabolisme allant jusqu'au DT2 en lien avec l'obésité chez les mâles et chez les femelles. D’autre part, des signes de cardiomyopathie ainsi qu’une modulation du taux des adipokines sont reliés à ces mêmes diètes. Parallèlement, l’activité de PPAR!2 est modulée chez les souris sous diètes enrichies en gras. Ensuite, nous avons démontré que les adipocytes, provenant de souris alimentées avec une diète enrichie en gras, modulaient la migration et la prolifération des CML comparativement au groupe contrôle. Ces modulations dépendaient en grande partie de la nature de la diète consommée, mais également du sexe de la souris. Par ailleurs, les altérations fonctionnelles des CML, couplées à des modulations géniques, sont associées aux changements du profil de sécrétion des adipokines mesurées chez les adipocytes. L’ensemble de ces travaux suggère une action directe de la nature de la stimulation du tissu adipeux blanc dans la modulation du profil de sécrétion des adipokines et l'induction du DT2 in vivo. Ces altérations de la physiologie adipocytaire se reflètent in vitro où le tissu adipeux contribue aux altérations physiopathologiques des CML liées au DT2. Ainsi, cette étude est l'une des premières à établir un lien direct entre les modulations adipocytaires et les effets de leurs sécrétions sur la physiologie des CML. Ces observations peuvent être exploitées cliniquement dans un développement futur d’outils thérapeutiques visant à prévenir et à traiter les troubles métaboliques et le DT2, en ciblant le tissu adipeux comme entité métabolique et endocrine. / Obesity is recognized as a risk factor to a variety of chronic diseases linked to the metabolic syndrome like atherosclerosis and type 2 diabetes (T2D), and is a major cause of increased risk of morbidity and mortality worldwide. High fat diets (HFD) coupled with sedentarity in the industrialized societies contribute to the raise of metabolic alterations prevalence specifically linked to endocrine troubles. Treatment of these latter should include the comprehension of the molecular mechanisms underlying these disorders in order to appropriately target factors responsible for the disease establishment. Adipose tissue is no longer considered as a passive organ which only stores lipids, but also works as an active gland that secretes several bioactive substances called adipokines. Among them, there are key factors known to play a pivotal role in the regulation of glucose and lipid homeostasis, lipid storage, adipogenesis. They are also recognized for their control of a wide range of cell type like adipocytes, hepatocytes and skeletal myocytes. Accumulation of adipose tissue in obesity, linked with the type as much as the amount of dietary lipids, is due to hyperplasia and hypertrophy of adipocytes. These changes are associated with modification in their secretion and inflammatory profile. To counteract excessive fat tissue development, insulin signalling known for its role in adipogenesis is inhibited. Thus, leptin is secreted by adipocytes to inhibit insulin action and the insulin sensitizer adipokine, adiponectin, is down regulated. The two factors are correlated to weight gain and their respective secretion profile is upregulated for leptin and down regulated for adiponectin. Insulin resistance is developed to prevent energetic storage and unlimited weight gain but glycemic control fails and glycaemia raises. Hyperglycaemia stimulates more insulin secretion, a characteristic of T2D linked to obesity. An estimated 80% of those who develop T2D are obese. Obesity induces important and complex changes, not only in glycemic homeostasis but also in the adipocytes. Following fatty acids (FA) stimulation, the main ligand-activated transcriptional factor that controls adipose tissue metabolism and adipokine secretion, peroxisome proliferator-activated receptor gamma (PPARg), is activated. This nuclear receptor subtype regroups two isoforms: PPARg1, expressed in many tissues (adipose tissue, muscle, heart and liver) where it controls glucose and lipid homeostasis, and PPARg2, the adipocyte’s specific form, which further governs preadipocyte differentiation, up-regulation of genes involved in lipogenesis and the expression of adipokines. Recent advances showed that increased FA and glycaemia trigger vascular alterations that lead to atherosclerosis. In fact, endothelial cells (EC) and smooth muscle cells (SMC), the main arterial components, are sensitive to metabolic alterations. A lack in insulin sensitivity, leading to lower glucose availability, forces arterial cells to use FA as alternative energy source. Thus, in atheroprone regions susceptible to plaque formation, EC and SMC are subjected to metabolic modifications that lead to oxidized low-density lipoprotein (oxLDL) accumulation in the intima and the progression of vascular disease. Many studies confirmed that the presence of SMC in the atherosclerotic plaque originates from the vascular wall but are showing a distinct phenotype. Even if the role of these cells in atherogenesis is not clear, trans-differentiation of SMC into foam cells has been reported in vitro. Thus, the present study aims at studying a HFD-induced obesity mouse model, developed to evaluate the impact of FA nature on the adipokine secretion profile of adipocytes. We also intended to determine gender-specific impact on modulation of metabolic disorders in response to those diets. On the other hand, we aim to determine the role of adipocytes in the development of obesity-linked atherosclerosis. For that, the second part of this study targeted the effect of adipocytes isolated from mice fed with HFD on SMC physiology. We focused our investigation on the effects of adipocytes regardless of the impact of other cell types in the adipose tissue. To reach our goal, we developed a HFD-fed mouse preparation demonstrating different stages of metabolic disorders leading to T2D. This model allowed us to generate adipocytes with different alteration status, reflected by the modulation of their adipokine secretion profile. Modifications in adipokine secretions were associated with PPAR!2 modulation. These results, reported in both genders, were delayed in female who expressed higher levels of estrogen receptor alpha (ER"). Then, the adipocytes were used to produce conditioned cultured media. To decipher the mechanistic contributions of HFD in adipokines modulation, the potential of adipocytes to induce SMC pathophysiologic disorders was evaluated in SMC stimulated by conditioned cultured media. This protocol enables the transposition of diet-induced fat cell modifications into extended alterations in the physiology of vascular SMC. These results strongly support pro-atherogenic effects of abdominal adipocytes on an important vascular component function through paracrine actions. Thus, adipocytes can be recognized as a link between the pathogenic potential of obesity and the impairments of SMC functions. A better understanding of the pathogenic effects of the adipose tissue on other tissues and organ systems might assist to develop better strategies in treating obesity- induced cardiovascular disease and metabolic syndrome.
713

Gene expression of tendon markers in mesenchymal stromal cells derived from different sources

Burk, Janina, Gittel, Claudia, Heller, Sandra, Pfeiffer, Bastian, Paebst, Felicitas, Ahrberg, Annette B., Brehm, Walter 15 December 2014 (has links) (PDF)
Background: Multipotent mesenchymal stromal cells (MSC) can be recovered from a variety of tissues in the body. Yet, their functional properties were shown to vary depending on tissue origin. While MSC have emerged as a favoured cell type for tendon regenerative therapies, very little is known about the influence of the MSC source on their properties relevant to tendon regeneration. The aim of this study was to assess and compare the expression of tendon extracellular matrix proteins and tendon differentiation markers in MSC derived from different sources as well as in native tendon tissue. MSC isolated from equine bone marrow, adipose tissue, umbilical cord tissue, umbilical cord blood and tendon tissue were characterized and then subjected to mRNA analysis by real-time polymerase chain reaction. Results: MSC derived from adipose tissue displayed the highest expression of collagen 1A2, collagen 3A1 and decorin compared to MSC from all other sources and native tendon tissue (p < 0.01). Tenascin-C and scleraxis expressions were highest in MSC derived from cord blood compared to MSC derived from other sources, though both tenascin-C and scleraxis were expressed at significantly lower levels in all MSC compared to native tendon tissue (p < 0.01). Conclusions: These findings demonstrate that the MSC source impacts the cell properties relevant to tendon regeneration. Adipose derived MSC might be superior regarding their potential to positively influence tendon matrix reorganization.
714

Impact of (pro)renin receptor deficiency in adipose tissue using a genetically engineered mouse model

Ahmed, Basma 12 1900 (has links)
La stimulation du récepteur de la rénine/prorénine [(P) RR], un membre récemment découvert du système rénine-angiotensine (SRA), augmente l'activité du SRA et des voies de signalisation angiotensine II-indépendante. Pour étudier l'impact potentiel du (P)RR dans le développement de l`obésité, nous avons émis l'hypothèse que les souris déficientes en (P)RR uniquement dans le tissus adipeux (KO) auront une diminution du poids corporel en ciblant le métabolisme du tissu adipeux, l'activité locomoteur et/ou la prise alimentaire. Ainsi, des souris KO ont été générées en utilisant la technologie Cre/Lox. Le gain de poids et la prise alimentaire ont été évalués hebdomadairement dans les mâles et femelles KO et de type sauvage (WT) pendant 4 semaines alors qu’ils étaient maintenu sur une diète normal. De plus, un groupe de femelles a été placé pour 6 semaines sur une diète riche en gras et en glucides (HF/HC). La composition corporelle et l'activité ambulatoire ont été évaluées par l’EchoMRI et à l’aide de cages Physioscan, respectivement. Les tissus adipeux ont été prélevés et pesés. De plus, les gras péri-gonadaux ont été utilisés pour le microarray. Finalement, le niveaux d'expression d'ARNm du (P)RR ont été évalués. Comme le gène du (P)RR est situé sur le chromosome X, les mâles étaient des KOs complets et les femelles étaient des KOs partielles. Les souris KO avaient un poids corporel significativement plus petit par rapport à WT, les différences étant plus prononcées chez les mâles. De plus, les femelles KOs étaient résistantes à l'obésité lorsqu'elles ont été placées sur la diète HF/HC et donc elles avaient significativement moins de masse grasse par rapport aux WTs. L’analyse histologique des gras péri-gonadaux des KOs nous ont dévoilés qu’il avait une réduction du nombre d'adipocytes mais de plus grande taille. Bien qu'il n'y ait eu aucun changement dans la consommation alimentaire, une augmentation de près de 3 fois de l'activité ambulatoire a été détectée chez les mâles. De plus, nous avons observé que leurs tibias étaient de longueur réduite ce qui suggère fortement l'affection de leur développement. Les gras péri-gonadaux des souris KO avaient une expression réduite de l`ABLIM2 (Actin binding LIM protein family, member 2) qui est associé avec le diabète de type II chez l'humain. Ainsi, les données recueillies suggèrent fortement que le (P)RR est impliquée dans la régulation du poids corporelle. / Stimulation of the (pro)renin receptor [(P)RR], a recently discovered member of the renin-angiotensin system (RAS), increases the activity of the RAS and stimulates angiotensin II-independent signaling pathways. To investigate the possible impact of the (P)RR on obesity development, we hypothesized that mice deficient in the (P)RR specifically in their adipose tissue (KO) would have a decrease in body weight by targeting adipose tissue metabolism, locomotor activity and/or food intake. As such, KO mice were generated using the Cre/Lox technology. Weekly weight gain and food intake were assessed in both male and female KO and wild-type (WT) littermates for 4 weeks on a normal diet. A group of females were also placed for an additional 6 weeks on a high-fat/high-carbohydrate diet (HF/HC). Body composition and physical activity were evaluated using EchoMRI and Physioscan cages, respectively. Adipose tissues were collected and weighed at sacrifice. Moreover, perigonadal fat was used for Gene assay and histological analysis. (P)RR mRNA expression levels were evaluated using real-time PCR. Different circulating metabolites and proteinuria were measured by ELISA kits. As the (P)RR gene is located on the X chromosome, males were complete KOs and females were partial KOs. KO body weights were significantly lower compared to WTs, the differences being more pronounced in males. Female KOs were resistant to obesity development when placed on a HF/HC diet and as such, had significantly smaller fat mass as well as lower circulating leptin levels compared to WTs. All KO perigonadal fat had a reduced number of adipocytes but of bigger size. Although there were no changes in food intake, an almost 3-fold increase in activity was detected in males. Moreover, they presented with shorter tibial length which strongly suggests that they may have developmental issues. Gonadal fat of KO mice showed a reduced expression of ABLIM2 gene (Actin binding LIM protein family, member 2) which is associated with type II diabetes in humans. Conversely, no obvious changes in glycemia were detected while tendencies for lower proteinuria could be observed. The data collected thus strongly suggests that the (P)RR is implicated in body weight regulation.
715

Separation of Water and Fat Signal in Magnetic Resonance Imaging : Advances in Methods Based on Chemical Shift

Berglund, Johan January 2011 (has links)
Magnetic resonance imaging (MRI) is one of the most important diagnostic tools of modern healthcare. The signal in medical MRI predominantly originates from water and fat molecules. Separation of the two components into water-only and fat-only images can improve diagnosis, and is the premier non-invasive method for measuring the amount and distribution of fatty tissue. Fat-water imaging (FWI) enables fast fat/water separation by model-based estimation from chemical shift encoded data, such as multi-echo acquisitions. Qualitative FWI is sufficient for visual separation of the components, while quantitative FWI also offers reliable estimates of the fat percentage in each pixel. The major problems of current FWI methods are long acquisition times, long reconstruction times, and reconstruction errors that degrade image quality. In this thesis, existing FWI methods were reviewed, and novel fully automatic methods were developed and evaluated, with a focus on fast 3D image reconstruction. All MRI data was acquired on standard clinical scanners. A triple-echo qualitative FWI method was developed for the specific application of 3D whole-body imaging. The method was compared with two reference methods, and demonstrated superior image quality when evaluated in 39 volunteers. The problem of qualitative FWI by dual-echo data with unconstrained echo times was solved, allowing faster and more flexible image acquisition than conventional FWI. Feasibility of the method was demonstrated in three volunteers and the noise performance was evaluated. Further, a quantitative multi-echo FWI method was developed. The signal separation was based on discrete whole-image optimization. Fast 3D image reconstruction with few reconstruction errors was demonstrated by abdominal imaging of ten volunteers. Lastly, a method was proposed for quantitative mapping of average fatty acid chain length and degree of saturation. The method was validated by imaging different oils, using gas-liquid chromatography (GLC) as the reference. The degree of saturation agreed well with GLC, and feasibility of the method was demonstrated in the thigh of a volunteer. The developed methods have applications in clinical settings, and are already being used in several research projects, including studies of obesity, dietary intervention, and the metabolic syndrome.
716

Peroxynitrite, pumps and perivascular adipose tissue studies across the physiological spectrum /

Reifenberger, Matthew Stanton, Milanick, Mark. January 2008 (has links)
The entire dissertation/thesis text is included in the research.pdf file; the official abstract appears in the short.pdf file (which also appears in the research.pdf); a non-technical general description, or public abstract, appears in the public.pdf file. Title from PDF of title page (University of Missouri--Columbia, viewed on April 6, 2010). Vita. Thesis advisor: Mark Milanick "June 2008" Includes bibliographical references
717

Dieta hiperlipídica materna e pós-natal promove remodelamento adverso do fígado, pâncreas e tecido adiposo na prole / Maternal and postnatal high fat diet provoke adverse liver, pancreas and adipose tissue remodelling in offspring

Bianca Martins Gregório 21 July 2010 (has links)
A dieta hiperlipídica (high-fat, HF) materna durante a gestação e/ou lactação aumenta a susceptibilidade da prole para o desenvolvimento de doenças crônicas na fase adulta. Verificar a hipótese que a ingestão materna de dieta HF nos períodos críticos de desenvolvimento (gestação e/ou lactação) predispõe à doença não alcoólica do fígado gorduroso e alterações pancreáticas e no tecido adiposo de camundongos machos adultos. Camundongos C57BL/6 fêmeas receberam durante a gestação e/ou lactação dieta padrão (standard chow, SC) ou HF. Filhotes machos foram divididos em cinco grupos: SC provenientes de mães SC; G provenientes de mães HF durante a gestação; L provenientes de mães HF durante a lactação; GL/HF provenientes de mães HF durante a gestação/lactação, mantendo a mesma dieta HF no período pós-natal (do desmame aos 3 meses deidade); GL provenientes de mães HF durante a gestação/lactação trocando a dieta para SC no período pós-natal (do desmame aos 3 meses deidade). Foi analisada ao longo do experimento a massa corporal da prole. No sacrifício (3 meses), o fígado, o pâncreas e a gordura epididimária foram removidos, pesados e processados e o sangue foi coletado para análise bioquímica. Ao nascimento e ao desmame, filhotes GL/HF foram mais pesados (+6% e +44%, p<0,05, respectivamente) que os filhotes SC. Os filhotes G apresentaram resistência à insulina e menor expressão do transportador de glicose no fígado (GLUT-2). A esteatose hepática foi observada nos grupos G, L, GL e principalmente nos filhotes do grupo GL/HF. A expressão hepática da proteína ligante de elementos regulatórios de esteróis (SREBP-1c) estava aumentada nos filhotes G, GL e GL/HF. Os filhotes G, GL e GL/HF apresentaram hipertrofia da ilhota pancreática e dos adipócitos quando comparados com o grupo SC. O consumo de dieta HF durante a gestação mostra-se ser o período mais prejudicial para os filhotes adultos de camundongos. A programação metabólica por dieta HF leva ao remodelamento adverso do fígado, do pâncreas e do tecido adiposo / Maternal high-fat diet (HF) during gestation and/or lactation period increases the susceptibility to development of chronic disease in offspring adult life. This work aimed to verify the hypothesis that maternal intake of high-fat diet in critical periods of pregnancy and/or suckling period predisposes to non alcoholic fatty liver disease, pancreatic and adipose tissue alterations in adulthood mice offspring. C57BL/6 female mice were fed, during gestation and/or lactation phases, with standard chow (SC) or HF diet. Male pups were divided into 5 groups: SC- from SC fed dam; G- from HF fed dam during gestation period; L- from HF fed dam during lactation period; GL- from HF fed dam during gestation and lactation periods and GL/HF- from HF fed dam during gestation and lactation, maintaining HF diet from post-weaning to adulthood. We analyzed body mass in all experiment, and at the euthanasia (3 mo-old), liver, pancreas and adipose tissue were removed, weighted and embedded. Blood was collected to biochemical analyses. At birth and at weaning, GL/HF pups were heavier than SC pups (+6% and +44%, p<0.05, respectively). G offspring showed insulin resistance and lower glucose transporter-2 expression (GLUT-2). Hepatic steatosis was present in G, L, GL and mainly in GL/HF offspring. Sterol regulatory element-binding protein-1c (SREBP-1c) expression was higher in G, GL and GL/HF offspring. It is important to mention that pancreatic islet hypertrophy and adipocyte hypertrophy were affected in G, GL and GL/HF offspring in comparison to SC. HF diet administration during gestation period is worse than lactation period. Furthermore, this type of programming by HF predisposes to adverse remodeling in liver, pancreas and adipose tissue in adult mice offspring
718

Prédicteurs de l’amélioration des facteurs de risques de diabète de type 2 suivant une diète hypocalorique

Provost, Viviane 12 1900 (has links)
No description available.
719

Efeitos da perda de peso corporal induzida por dieta hipolip?dica ad libitum e pela restri??o cal?rica com dieta hiperlip?dica na inflama??o do tecido adiposo de camundongos obesos

Rodrigues, Manuela Ortega Marques 01 December 2017 (has links)
Submitted by Jos? Henrique Henrique (jose.neves@ufvjm.edu.br) on 2018-03-26T12:48:59Z No. of bitstreams: 2 license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) manuela_ortega_marques_rodrigues.pdf: 2356674 bytes, checksum: e576d7cb84dd67e4068acfffffe22e9f (MD5) / Approved for entry into archive by Rodrigo Martins Cruz (rodrigo.cruz@ufvjm.edu.br) on 2018-03-29T12:57:38Z (GMT) No. of bitstreams: 2 license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) manuela_ortega_marques_rodrigues.pdf: 2356674 bytes, checksum: e576d7cb84dd67e4068acfffffe22e9f (MD5) / Made available in DSpace on 2018-03-29T12:57:38Z (GMT). No. of bitstreams: 2 license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) manuela_ortega_marques_rodrigues.pdf: 2356674 bytes, checksum: e576d7cb84dd67e4068acfffffe22e9f (MD5) Previous issue date: 2017 / Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico (CNPq) / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior (CAPES) / Funda??o de Amparo ? Pesquisa do Estado de Minas Gerais (FAPEMIG) / A expans?o do tecido adiposo branco na obesidade leva ? express?o alterada de prote?nas em seus adip?citos, bem como a infiltra??o de c?lulas do sistema imune, especialmente macr?fagos, cujas secre??es levam ao desenvolvimento da inflama??o cr?nica de baixo grau, a qual ? considerada subjacente ao desenvolvimento de in?meras comorbidades. Dentre as formas de tratamento da obesidade, dietas de restri??o cal?rica (RC) nutricionalmente balanceadas induzem a perda de peso e melhorias em marcadores sist?micos da inflama??o, mas os efeitos diretos no tecido adiposo visceral ainda s?o controversos. No entanto, existe uma lacuna sobre qual o impacto dessas dietas na inflama??o local, mesmo em condi??es de sobrecarga lip?dica. Assim, o objetivo deste estudo foi avaliar os efeitos da perda de peso corporal induzida por dieta hipolip?dica ad libitum e pela restri??o cal?rica com dieta hiperlip?dica na inflama??o do tecido adiposo visceral de camundongos obesos. Para tal, inicialmente, camundongos C57BL/6 com 12 semanas de idade, machos, foram divididos em dois grupos: LF ? alimentados com dieta controle hipolip?dica ? do ingl?s low fat (10% das calorias, fonte ?leo de soja, rica em ?cidos graxos poli-insaturados); e HF ? alimentados com dieta controle hiperlip?dica ? do ingl?s high fat (60% calorias, fonte banha de porco, rica em ?cidos graxos saturados) para indu??o da obesidade. Ap?s oito semanas, seis animais de cada grupo foram eutanasiados para verifica??o da adiposidade visceral e estado inflamat?rio (dosagens de prote?na C reativa ? PCR s?rica e hep?tica). Em seguida, os animais HF foram aleatoriamente divididos em tr?s grupos HF ? continuaram recebendo dieta HF; LFAL ? submetidos ao emagrecimento pela substitui??o da dieta HF pela LF e acesso livre (ad libitum) e RHF ? submetidos ao emagrecimento por receberem quantidades restritas em calorias da dieta HF para atingir o mesmo peso corporal dos animais LFAL. A partir deste momento, esses grupos foram alimentados, juntamente com os animais LF, por mais sete semanas. Ao final, foram avaliados o ganho/perda de peso corporal, a adiposidade, as concentra??es s?ricas e hep?ticas de PCR, e as concentra??es de leptina, adiponectina, e das citocinas IL-6, TNF e MCP-1 no tecido adiposo retroperitoneal, al?m da morfologia dos adip?citos e a presen?a de infiltrados inflamat?rios no tecido adiposo retroperitoneal. Ao final da fase de indu??o da obesidade, os animais HF estavam obesos e inflamados. Ao final da fase de indu??o da perda de peso, os grupos LFAL e RHF tiveram pesos corporais semelhantes, menores que o HF e se igualaram ao LF. No entanto, houve maior dificuldade em perder peso pelo grupo RHF em compara??o ao LFAL, dado pelas diferen?as significativas entre os deltas de perda de peso, que foram menores para RHF e pelos coeficientes de efici?ncia energ?tica, que foram maiores para o grupo RHF. Os animais LFAL retornaram a adiposidade e a hipertrofia dos adip?citos viscerais a valores semelhantes ao grupo LF. Isto provavelmente foi o que levou ? menor concentra??o de leptina com concomitante aumento da adiponectina e menor infiltra??o de c?lulas inflamat?rias neste tecido, igualando-se tamb?m ao LF. Em consequ?ncia, houve menor concentra??o tecidual de citocinas pr?-inflamat?rias, al?m de menor concentra??o hep?tica e circulante de PCR. J? para os animais RHF, houve apenas atenua??o da adiposidade e da hipertrofia dos adip?citos retroperitoneais. Isso foi suficiente para restabelecer a concentra??o local de leptina a n?veis semelhantes ao grupo LF, embora n?o tenha elevado a concentra??o de adiponectina. Al?m disso, a infiltra??o de c?lulas inflamat?rias menteve-se tamb?m elevada. N?o houve redu??o da concentra??o de citocinas pr?-inflamat?rias, ? exce??o da IL-6, que reduziu levemente. A concentra??o hep?tica de PCR foi atenuada, o que n?o refletiu na concentra??o s?rica dessa prote?na. Concluiu-se que a restri??o cal?rica com dieta hiperlip?dica foi menos eficiente em promover a perda de peso e de adiposidade e n?o melhorou a inflama??o do tecido adiposo visceral, comparada com a dieta hipolip?dica ad libitum. Inferiuse que a ingest?o de dieta com sobrecarga de lip?deos (60% das calorias) e de ?cidos graxos saturados foi mais determinante da inflama??o local do que a restri??o cal?rica per se. / Disserta??o (Mestrado) ? Programa Multic?ntrico de P?s-gradua??o em Ci?ncias Fisiol?gicas, Universidade Federal dos Vales do Jequitinhonha e Mucuri, 2017. / The expansion of white adipose tissue in obesity leads to altered protein expression in its adipocytes, as well as the infiltration of immune cells, especially macrophages, whose secretions lead to the development of chronic low-grade inflammation, which underlies the development of several comorbidities. Among treatments, caloric restriction (CR) nutritionally balanced diets induce weight loss and ameliorates inflammation systemic markers, but adipose tissue effects are still controversial. Moreover, there is a gap on the impact of these diets on local inflammation, even under lipid overload. Thus, the aim of this study was to evaluate effects of body weight loss induced by a low fat ad libitum diet and a CR in a high fat diet in the visceral adipose tissue inflammation of obese mice. Firstly, 12 weeks of age male C57BL/6 mice were divided into two groups: LF - fed a control low fat diet (10% calories, source soybean oil, high in polyunsaturated fatty acids); and HF - fed a control high fat diet (60% calories, source lard, high in saturated fatty acids) for obesity induction. After eight weeks, six animals from each group were euthanized to verify visceral adiposity and inflammatory status (serum and hepatic C-reactive protein-CRP). Then, HF animals were randomly divided into three groups: HF ? keept at HF diet; LFAL - a weight loss group that was switched from HF to LF and maintained on it ad libitum; RHF - a weight loss group that received restricted amounts of HF to maintain the same body weight as LFAL. Thereafter, these groups were fed, along with the LF animals, for another seven weeks. At end, body weight gain / loss, adiposity, serum and hepatic CRP concentrations, and adipose retroperitoneal tissue concentrations of leptin, adiponectin, IL-6, TNF and MCP-1 were evaluated, as well as adypocite morphology and the presence of inflammatory infiltrates in the retroperitoneal adipose tissue. Obesity was induced, since HF animals had higher weights, adiposity and were inflamed. At the end of the weight loss period, both LFAL and RHF had similar body weight, lower than HF and equal to LF. However, it was more dificcult to loose wheight by the RHF group compared to LFAL, since weight loss deltas were lower for RHF and energy efficiency ratios were higher for RHF group. LFAL animals returned visceral adiposity and retroperitoneal adipocyte hypertrophy similarly to the LF group. Also, there was a lower leptin level with concomitant increase of adiponectin and less infiltration of inflammatory cells in this tissue, also matching to LF. Still, there was a lower tissue concentration of proinflammatory cytokines, and a lower hepatic and serum CRP. For RHF animals, there was only an attenuation in adiposity and visceral adipocyte hypertrophy, although it was sufficient to restore local leptin concentration similarly to LF. However, this regimen was not able to elevate the adiponectin concentration. In addition, the inflammatory cells infiltration was highly elevated. There was no reduction in proinflammatory cytokines concentration, despite IL-6, which was reduced slightly. Hepatic CRP concentration was attenuated, which did not reflect in its serum concentrations. In mice with diet-induced obesity, the weight loss by means a CR in a high fat diet was less effective in promoting wheight and adiposity losses and it did not improve visceral adipose tissue inflammation. It can be inferred that a lipid overload (60% from calories) as well as a saturated fatty acid surplus from the high fat diet were more determinant of local inflammation than caloric restriction per se.
720

Etude de la fertilité et du métabolisme des vaches laitières sélectionnées pour l'haplotype "fertil+" ou "fertil-" à un QTL de fertilité situé sur le chromosome 3 / Fertility and metabolism of dairy cows carrying "Fertil+" or "Fertil-" haplotype for a fertility QTL located on the chromosome 3

Coyral-Castel, Stéphanie 06 July 2012 (has links)
Au cours des dernières décennies, une dégradation de la fertilité des vaches laitières, parallèlement à une augmentation de la production laitière a été observée. Des régions du génome, les QTL, affectent la fertilité femelle. Le but de ce travail de thèse est d’étudier la fertilité et certains paramètres zootechniques chez des vaches Prim'Hosltein en première lactation choisies pour leur haplotype favorable "fertil+" ou défavorable "fertil-" pour un QTL de fertilité situé sur le chromosome 3. Ce phénotypage a montré une meilleure fertilité et un meilleur bilan énergétique dans la première semaine de lactation pour les vaches "fertil+" par rapport aux vaches "fertil-". De plus, les vaches "fertil-" ont un flux d’ingestion plus rapide. Au pic de mobilisation, certains gènes du QTL étaient différentiellement exprimés dans le tissu adipeux des deux haplotypes. Dans les cellules de la granulosa, un de ces gènes, nommé Kirrel, est plus exprimé chez les vaches "fertil+" et sa protéine recombinante inhibe la sécrétion de progestérone in vitro. Notre travail a permis d'affiner les interactions génotype-phénotype liées à un QTL de fertilité et de mettre en avant un des possibles rôles d'un gène de ce QTL dans la fonction de reproduction chez la vache laitière. / In recent decades, the dairy cow fertility has declined, in parallel with an increase in milk production. Some regions of the genome, named QTL, affect female fertility. The purpose of this thesis is to study fertility and some zootechnical parameters in Prim'Hosltein cows in first lactation chosen for their favorable haplotype "fertil+" or unfavorable haplotype "fertil-" for one fertility QTL on chromosome 3. This phenotyping showed better fertility and energy balance in the first week of lactation for "fertil+" than for "fertil-" cows. In addition, "fertil-" cows had a higher eating rate. At the peak of mobilization, the QTL genes are differentially expressed in adipose tissue of "fertil+" and "fertil-" cows. In granulosa cells, one of these genes, named Kirrel, is higher expressed in "fertil+" cows and its recombinant protein inhibits the secretion of progesterone in vitro. Our work has contributed to refine interactions genotype-phenotype linked to one fertility QTL and highlighted one of the possible roles of a gene which belongs to this QTL in the reproductive function in dairy cows.

Page generated in 0.0582 seconds